Vycor Medical to Present at the 4th Annual Liolios Gateway Conference on September 10, 2015
(firmenpresse) - BOCA RATON, FL -- (Marketwired) -- 08/31/15 -- (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, has been invited to present at the being held on September 9-10, 2015 at the Four Seasons Hotel San Francisco.
Vycor CEO Peter Zachariou is scheduled to present on Thursday, September 10 at 12:00 p.m. Pacific time. He will be joined by President David Cantor for one-on-one meetings held throughout the conference.
The presentation will be webcast live at and available for replay on the Gateway Conference website at .
To receive additional information, request an invitation or to schedule a one-on-one meeting, please email .
The 4th Annual Gateway Conference is an invite-only conference presented by Liolios, which brings together the most compelling companies with the nation's top institutional investors and analysts. This year's event features more than 90 companies from a number of growth industries, including technology, business and financial services, consumer, digital media, clean technology and life sciences. The format has been designed to give attendees direct access to senior management via company presentations, Q&A sessions and one-on-one meetings. For more information, visit or .
Vycor Medical (OTCQB: VYCO) is dedicated to providing the medical community with innovative and superior surgical and therapeutic solutions. The company has a portfolio of FDA cleared medical solutions that are changing and improving lives every day. The company operates two business units: Vycor Medical and NovaVision, both of which adopt a minimally or non-invasive approach.
Vycor Medical's ViewSite™ Surgical Access Systems (VBAS) is a suite of clear cylindrical minimally invasive disposable devices that hold the potential for speedier, safer and more economical brain surgeries and a quicker patient discharge. VBAS is designed to optimize neurosurgical site access, reduce patient risk, accelerate recovery and add tangible value to the professional medical community. The company is ISO 13485:2003 compliant, has U.S. FDA 510(k) clearance for brain and spine surgeries and full regulatory approvals for brain in Australia, Brazil, Canada, China, Europe (EU - Class III), Korea and Japan and is seeking or has partial regulatory approvals in India, Russia, Taiwan and Vietnam. For an overview of Vycor Medical's VBAS, see .
NovaVision provides non-invasive, computer-based rehabilitation targeted at a substantial and largely un-addressed market of people who have lost their sight as a result of stroke, or brain injury.
NovaVision's family of therapies both restore and compensate for lost vision. NovaVision's VRT is the only medical device aimed at the restoration of vision lost as a result of neurological damage which has FDA 510(k) clearance to be marketed in the U.S. NeuroEyeCoach is a compensation therapy registered in the US as a Class I 510(k) exempt device, VRT and NeuroEyeCoach are highly complementary and provided to patients in an Internet-delivered suite, to ensure broad benefits to patients.
For the latest information on the company, including media and other coverage, and to learn more, visit , or .
Liolios Group, Inc.
Ronald A. Both
Tel 1-949-574-3860
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 31.08.2015 - 12:31 Uhr
Sprache: Deutsch
News-ID 416866
Anzahl Zeichen: 0
contact information:
Town:
BOCA RATON, FL
Kategorie:
Medical Devices
Diese Pressemitteilung wurde bisher 230 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Vycor Medical to Present at the 4th Annual Liolios Gateway Conference on September 10, 2015"
steht unter der journalistisch-redaktionellen Verantwortung von
Vycor Medical, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
